Mu Bie Zi (Momordica Seeds)

Chinese Herb Actions

Chinese Herb Dosage

• What is the typical dosage of Mu Bie Zi, and how is it normally used?

  Mu Bie Zi is used almost entirely externally — ground to a powder and mixed into a paste with vinegar or oil, made into a juice, or decocted as a wash, applied directly to the affected area. Because the raw seed is toxic, it is not eaten or decocted as an ordinary internal ingredient.

  Where internal use is described at all, sources give small, processed-form doses only:

  • Pills/powder (processed, defatted form): commonly cited around 0.5–1.5 g, with the Chinese Pharmacopoeia figure of about 0.9–1.2 g/day; one review notes clinical decoctions in the 8–12 g range, but this is not the traditional primary route of administration for this herb.
  • External paste/wash: quantity is fitted to the size of the sore or swelling rather than a fixed gram dose.

  Note: Internal dosage figures vary between sources (0.5–1.5 g vs. 8–12 g for decoctions) — likely reflecting different preparations (processed defatted powder vs. crude decoction) rather than one agreed figure. Given the herb’s documented toxicity, any internal use belongs under a qualified TCM practitioner using a properly processed product, not a general reference dose.

  Source: multiple online sources; Momordicae Semen pharmacology/toxicology review, PMC 12649813. Reference only — not a prescription.

Chinese Herb Contraindications & Cautions

• Are there cautions for Mu Bie Zi?

  Mu Bie Zi is classified as toxic and is contraindicated in pregnancy and in weak or debilitated patients; it is intended for topical/external use, with any internal use restricted to small amounts of a properly processed (defatted) product under professional supervision. It should not be applied to broken skin, open wounds, or near the eyes and mucous membranes without practitioner guidance, given documented toxicity on systemic absorption.

  • Pregnancy — contraindicated.
  • Weak/debilitated constitution — contraindicated per materia medica reference.
  • Raw, unprocessed seed — more toxic than the processed (defatted) form; raw internal use is not standard practice.

  Source: multiple online sources (contraindications); Momordicae Semen pharmacology/toxicology review, PMC 12649813. Reference note, not a substitute for professional guidance.

Chinese Herb Toxicity & Overdose

• Documented toxic. Momordicae Semen (Mu Bie Zi) contains saponins and cochinchinin, concentrated mainly in the seed kernel, identified in preclinical studies as its principal toxic constituents. Reported animal LD50 values include roughly 146 mg/kg (aqueous extract, intraperitoneal, mice), about 4.03 g/kg (water extract, oral, mice), and 16 mg/kg (cochinchinin, intraperitoneal, mice); an isolated saponin fraction has a reported oral LD50 near 0.96 g/kg in mice. Long-term administration in rats has been associated with increased heart, liver, and spleen organ indices, and zebrafish studies have reported cardiotoxicity (pericardial edema, cardiac apoptosis, reduced blood flow). Traditional processing — stir-baking and pressing out the oil — measurably raises the LD50 (i.e., reduces toxicity) compared with the raw seed, which is the basis for restricting this herb to external use, or small processed internal doses under supervision.

  Source: Momordicae Semen pharmacology/toxicology reviews, PMC 12649813 and PMC 6864475. Reference note on documented preclinical toxicity, not a safety guarantee.

• This herb is considered toxic.
  (while some Chinese herbs are toxic, it must be noted that many come prepared, or are combined, to mitigate their toxicity)

Herb-Drug Interactions

• No well-established clinical herb–drug interactions are documented in the literature reviewed. Given the preclinical signals of cardiac and hepatic toxicity at higher doses (see toxicity), practitioner caution is reasonable when combining with other cardiotoxic or hepatotoxic substances/medications — this is precautionary, not a demonstrated clinical interaction. (Flagged for practitioner confirmation.)

Western / Biomedical Research

Chinese Herb Clinical Studies & Research

Provided as research context — a summary of published biomedical study, not a therapeutic or medical claim.

• Is there modern research on Mu Bie Zi (Semen Momordicae / Momordica cochinchinensis)?

  Yes — mostly preclinical (cell and animal) pharmacology and toxicology, with no clinical trials identified for its traditional sores/swelling indications. Modern reviews describe more than 60 isolated constituents, chiefly triterpenoid saponins, with anti-tumor, anti-inflammatory, antioxidant, and wound-healing activity reported in laboratory studies.

  • Anti-tumor (preclinical) — seed extracts/fractions have shown antiproliferative and pro-apoptotic effects against breast, lung, melanoma, gastric, esophageal, and cervical cancer cell lines in laboratory studies; not evidence of clinical anti-cancer efficacy.
  • Melanoma cytotoxicity (cell study) — a water extract of the seed showed cytotoxic potency toward melanoma cells comparable in vitro to the drugs vemurafenib and cisplatin, with relative sparing of normal keratinocytes, acting via TNFR1 upregulation and NF-κB suppression; cell-culture evidence only.
  • Gastric ulcer healing (animal) — an aqueous-ethanol seed extract (SK-MS10) given orally accelerated healing of acetic-acid-induced gastric ulcers in rats, reducing ulcer area by roughly two-thirds versus control by day 14, via increased VEGF expression and angiogenesis; animal model, not a clinical outcome.
  • Toxicology and processing — reviews consolidate the LD50 data above and confirm that traditional stir-baking/defatting substantially lowers toxicity versus the raw seed, supporting the traditional external-use-first, processed-internal-dose-second practice.

  Overall, pharmacological interest is real but the evidence base is preclinical; no human clinical trials on Mu Bie Zi for its traditional indications were located.

  Sources: DOI 10.2147/DDDT.S555032, PMC 12649813 (phytochemistry/pharmacology/toxicology/processing review); PMID 30931848, DOI 10.2174/1381612825666190329123436 (Curr Pharm Des review); PMID 31683690, PMC 6864475, DOI 10.3390/molecules24213949 (anti-tumor components review); PMID 20514308, PMC 2877244, DOI 10.3346/jkms.2010.25.6.875 (gastric ulcer healing, rat); PMID 36678596, PMC 9864523, DOI 10.3390/ph16010100 (melanoma cytotoxicity, cell study). Research context, not a therapeutic claim.

Chinese Herb Notes

• What is Mu Bie Zi combined with, and how is it processed?

  Mu Bie Zi is traditionally paired with other externally-applied, toxicity-resolving herbs, and is processed before any internal use to reduce its toxicity. The Sacred Lotus formula database currently has no formulas linked to this herb, so the combinations below are drawn from external materia medica references rather than in-house formula data.

  • With Huang Qin, Huang Bai, and Gua Lou — for chronic, slow-draining abscesses (traditional combination, external reference source).
  • With Ba Dou (Croton Fruit), Ru Xiang (Frankincense), and Bai Fan (Alum) — for pus-filled sores needing to be drawn out.
  • With Ku Shen (Sophora Root) — for throat swelling.
  • With vinegar — ground into a paste for topical use, including traditionally for dental pain.

  Processing: the traditional processed form — stir-baked kernels pressed to remove the oil and ground to a fine powder (sometimes called Momordica “frost powder”) — substantially lowers toxicity compared with the raw seed, and is the form used whenever any internal administration is considered.

  Source: multiple online sources (combinations); Momordicae Semen review, processing section, PMC 12649813. Traditional formula context, not treatment advice.

This herb is considered toxic